Please login to the form below
Seroquel
This page shows the latest Seroquel news and features for those working in and with pharma, biotech and healthcare.
AstraZeneca divests Seroquel rights to focus on key therapy areas
AZ will continue to manufacture and supply Seroquel and Seroquel XR to Cheplapharm during a transition period. ... In 2018, Seroquel reported sales of $36m in the markets included in this agreement, while Seroquel XR generated $79m.
Latest news
-
Daily Brief: Italy in turmoil, Pharma attacks Europe's generics move and more
AstraZeneca for rights to its former blockbuster Seroquel and Seroquel XR in international markets. ... The company says it will now build commercial operations in Europe, and sees the Seroquel brands as complementary to its CNS portfolio.
-
AZ expects return to growth this year after 2017 decline
to $2.6bn, although the cumulative effect of patent expiries - which also affect antipsychotic Seroquel XR (quetiapine) and gastrointestinal drug Nexium (esomeprazole) - are starting to dissipate.
-
AZ CEO says company’s renaissance is on track
for cholesterol drug Crestor (rosuvastatin) and antipsychotic Seroquel XR (quetiapine).
-
Patent cliff losses set to cost pharma $65bn by 2019
GlobalData analyst Adam Dion said: “AZ, CNS segment has been bleeding sales as a result of the company losing its patent on Seroquel (quetiapine), a treatment for bipolar disorder.
-
Abilify Maintena launches in Europe
Zyprexa (olanzapine) and AstraZeneca's Seroquel (quetiapine) - now available generically.
More from news
Approximately 3 fully matching, plus 73 partially matching documents found.
Latest Intelligence
-
Who tops the pharma list?
For example, patents for Seroquel (AstraZeneca - 2011 revenues of $5.8bn), Zyprexa (Eli Lily - $4.6bn) and Concerta (J&J - $1.3bn) had all expired by May 2012.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- First patients dosed with COVID-19 vaccine from SpyBiotech and Serum Institute of India
- Gavi says 76 wealthy countries have committed to COVAX vaccine facility
- Regeneron launches phase 3 COVID-19 antibody trial in the UK
- First patients dosed with COVID-19 vaccine from SpyBiotech and Serum Institute of India
- Positive COPD data for Synairgen's SNG001 supports COVID-19 programme
- Roche’s Ocrevus boasts positive long-term data in MS
- Building Stakeholder Relationships in the New Normal
- Personalized Digital Health Coaching
- Empowering Medtech Innovation
- Eli Lilly reports first results for COVID-19 targeting antibody
- Lilly’s Olumiant combined with Gilead’s remdesivir hits the mark in COVID-19
- 7 important considerations for creating an inclusive clinical trial website
Latest intelligence
- 7 important considerations for creating an inclusive clinical trial website
- You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...
- Route 66: can remote working put two-thirds of us back on the road to engaged employment?
- Pre-pandemic, 66% of the world’s workforce weren’t engaged in their jobs – Chris Ross examines how the rush to remote working has impacted employee engagement...
- Demonstrating the value of HCP self-serve portals
- Develop the art of setting KPIs and metrics aligned to your specific objectives, target personas, key educational messages, content, website features and journeys....
Quick links
Infographics
